Overview

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Status:
Recruiting

Trial end date:
2027-12-27

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Phase:

Phase 3

Details

Lead Sponsor:

Bristol-Myers Squibb